News

  1. New analysis reveals reduction in valproate prescribing

    Prescribing of valproate has reduced significantly following the introduction of a quality improvement programme that promotes safety and patient choice. New analysis presented to the National Patient Safety Committee shows: a 53% reduction in initiation in girls aged 0-12 a 60% reduction in 13-54 women started on valproate a 65% reduction in women re-starting valproate […]

    Read more of: New analysis reveals reduction in valproate prescribing
  2. Review finds safety recommendations system ‘untenable’

    The current situation on recommendations for safety and quality in healthcare is untenable according to a new review. The DHSC-commissioned review was published by HSSIB on behalf of a group of ALBs. It concludes that the substantial number of recommendations made to the healthcare system means providers struggle to prioritise and implement recommendations. It found […]

    Read more of: Review finds safety recommendations system ‘untenable’
  3. PSC welcomes new guidance on valproate usage by men

    Men taking valproate and their partners are being advised to use effective contraception according to new guidance from the MHRA. It recommends that male patients and their partners use effective contraception during valproate treatment and for at least three months after stopping the medication. It follows a study which reports a possible association between valproate […]

    Read more of: PSC welcomes new guidance on valproate usage by men